• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

What difference do antimicrobials make? (Proceedings)

August 1, 2010
Michael D. Apley, DVM, PhD, DACVCP

Antimicrobial efficacy in cattle can be evaluated through clinical studies including a negative control group. To be included here, the study must have specified that the subjects were randomized, the evaluators were masked to treatment, and that statistical analysis was applied. Much of the data were compiled from Food and Drug Administration Freedom of Information (FOI) summaries for veterinary drug approvals.

Antimicrobial efficacy in cattle can be evaluated through clinical studies including a negative control group. To be included here, the study must have specified that the subjects were randomized, the evaluators were masked to treatment, and that statistical analysis was applied. Much of the data were compiled from Food and Drug Administration Freedom of Information (FOI) summaries for veterinary drug approvals. Study outcomes were evaluated by two calculated parameters. Attributable risk reduction (ARR) determines the difference in actual occurrence of an outcome (e.g., an improvement in clinical success from 40% in the controls to 60% in the treated group is an ARR of 20%). Number needed to treat (NNT) is the number of animals that would need to be treated before a difference in outcome would be observed, calculated as 1/ARR (e.g., in the example above, the NNT would be 1/0.2, or 5).

Advertisement

Seventeen bovine respiratory disease (BRD) therapeutic studies incorporating 22 different positive treatment groups displayed a treatment success ARR range of 12% to 92% with an ARR median of 49% and median NNT of 2. Seven BRD control studies involving 5 drug regimens displayed an ARR range for reduction in morbidity of -3.3% to -48.8% with an ARR median of -11.7% and a median NNT of 9. Footrot studies included 4 antimicrobials in 11 studies with an ARR range for treatment success from 33.3% to 77.0% with median ARR and NT values of 52.0% and 2, respectively. Other infectious diseases in cattle were also evaluated.

Related Content:

Medical
Traditional and holistic treatments for giardia
Traditional and holistic treatments for giardia
3 Must-reads for National Poison Prevention Week
3 Must-reads for National Poison Prevention Week
UC Davis study on eye diseases in kittens
UC Davis study on eye diseases in kittens

Advertisement

Latest News

Pet Advocacy Network honors outstanding contributions to the pet care community

Traditional and holistic treatments for giardia

ASU trustees approve the creation of a new veterinary school

6 tips for first-time dog owners

View More Latest News
Advertisement